Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11702469 Recombinant EGFL7, EGFL7 antibodies, and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

117024690

Date of Patent

July 18, 2023

Patent Application Number

166079300

Date Filed

April 24, 2018

Patent Citations

‌

US Patent 8574576 Humanized anti-EGFL7 antibodies and methods using same

‌

US Patent 8398976 Antibodies to EGFL7 and methods for their use

Patent Citations Received

‌

US Patent 11945785 Pyrazine compounds as inhibitors of FLT3

Patent Primary Examiner

CPC Code

...

The present disclosure relates to recombinant EGFL7, EGFL7 antibodies, and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11702469 Recombinant EGFL7, EGFL7 antibodies, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API